Rhode Island Society of Health System Pharmacists
RISHP LUNCH & LEARN 11: WEIGHing SGLT2 Inhibitor & GLP-1 Agonist Effects on Body Weight in Type 2 Diabetes
Pharmacists
Wednesday January 27, 2021
12:00pm to 1:00pm
Online Webinar and Home Study - Registration Details in Confirmation Email
Topics:
RISHP LUNCH & LEARN 11: WEIGHing SGLT2 Inhibitor & GLP-1 Agonist Effects on Body Weight in Type 2 Diabetes
Mark Lasorsa, PharmD, PGY2 Ambulatory Care Resident, Rhode Island Hospital
Preceptors: Laura McAuliffe, PharmD, BCACP, CDE, Director, PGY-2 Ambulatory Care Pharmacy Residency Program and Ruth Dapaah-Afriyie, PharmD, BCACP, CDOE, CVDOE, Senior Clinical Pharmacist Specialist
Preceptor: Justin Huynh, PharmD, BCOP, Clinical Pharmacy Specialist, Hematology/Oncology, Director, PGY-2 Oncology Pharmacy Residency Program, Rhode Island Hospital | Lifespan Cancer Institute
Members: FREE
Non-Members: $10
Please register on-line only. Please do not mail in registrations. Fees are payable at sign-in or online via Paypal Online:http://www.rishp.org. Refund requests must be made by written request and are at the discretion of the RISHP Board of Directors.
Learning Objectives
At the completion of this activity, pharmacists will be able to:
1. Describe the epidemiology and impact of obesity and Type 2 Diabetes.
2. Explain the pathophysiology and significance of weight loss affecting Type 2 Diabetes.
3. Summarize current American Diabetes Association guideline recommendations for obesity and glycemic management in Type 2 Diabetes.
4. Identify Sodium Glucose Cotransporter 2 (SGLT2) inhibitor mechanisms and trials demonstrating weight loss in Type 2 Diabetes.
5. Identify Glucagon-Like Peptide 1 (GLP-1) Agonist mechanisms and trials demonstrating weight loss in Type 2 Diabetes.
6. Describe the rationale for the combination of Sodium Glucose Cotransporter 2 (SGLT2) inhibitors and Glucagon-Like Peptide 1 (GLP-1) Agonists for additive weight loss in Type 2 Diabetes.
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based educational activity. Pharmacists will receive 1.0 live contact hour (0.1 ceus) for the educational activity. No partial credit is available.
UNIVERSAL ACTIVITY NUMBERS (UANs):
Live Online: 0060-9999-21-001-L01-P
PROGRAM EVALUTION
All participants will have the opportunity to evaluate the educational session and speaker and to identify future educational needs.
REQUIREMENTS FOR CE CREDIT
A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date (1/27/2021) in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.
FACULTY DISCLOSURE
The faculty have no disclosures to report.
